Canakinumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Canakinumab and local guidelines before prescribing.

Biologic (anti-IL-1)

Mechanism

Anti-IL-1 beta monoclonal antibody.

Uses

Periodic fever syndromes, Still disease, gout flares.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infections, injection-site reactions, neutropenia.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection

Monitoring

FBC

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Screen for TB.

More from the textbook: uses, cautions and other points
Where it is discussed in the book